The underlying mechanisms may be partly due to the activation of CaSR which can promote NF-κB expression and enhance PTHrP release, thus eventually promoting the development of bone metastasis in lung adenocarcinoma. The gene discussed is NFKB1; the disease is lung adenocarcinoma.